NC Fast Facts: FDA approves breakthrough brain cancer drug linked to Duke trial
DURHAM — The Preston Robert Tisch Brain Tumor Center at Duke recently announced patients with low-grade glioma brain tumors, a deadly form of brain cancer, now have a new treatment option for the first time […]